+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 75Years +
All Genders
ID07007156

Evaluating NECPAL Scale Use to Predict 90-Day Mortality in ICU Patients Aged 75 and Older

Led by Consorci Sanitari de l'Alt Penedès i Garraf · Updated on 2026-11-04

199

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the usefulness of the NECPAL scale to identify patients admitted to the Intensive Care Unit ICU who may have a higher risk of dying within 90 days of ICU admission. This observational study focuses on older adults aged 75 years or older in the ICU setting. The study is sponsored by Consorci Sanitari de lAlt Peneds i Garraf. Participants are observed based on their NECPAL scale results, with one group having a positive NECPAL result. The study does not involve any treatment or intervention but collects data to assess the association between a positive NECPAL score and mortality risk. During the study, participants health status and outcomes are monitored for up to 90 days from ICU admission. Researchers measure mortality within this timeframe to evaluate the NECPAL scales predictive value. The study involves informed consent from participants or their legal representatives and excludes those who die within the first 24 hours of ICU admission.

CONDITIONS

Brief Title

Is a Positive NECPAL in ICU Patients Associated With Higher Mortality

Research Team

D

Diana Gutiérrez, MD

N

Noemí Casaponsa

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here